Invitae

360Dx Top 30 Drops 5 Percent in June

Invitae Q1 Revenues Increase 19 Percent

Cardiology Genomic Testing Alliance Formed by Five Companies

Invitae Q4 Revenues Increase 26 Percent

Invitae Garners CE-IVD Mark for Two Comprehensive Genomic Profiling Tests

Invitae Launches Ciitizen Genome Information Management Platform at JPM

360Dx Index Rises 20 Percent in 2021

360Dx Index Grows 4 Percent in December Alongside Broader Markets

360Dx Index Follows Larger Market Trends, Drops 4 Percent in November

Invitae Sues Natera Over Alleged Infringement of Sequence Assembly Patents

Invitae Q3 Revenues Increase 66 Percent

Invitae, Outcomes4Me Collaborate to Improve Breast Cancer Genetic Testing Access

Invitae to Acquire Consumer Health Tech Firm Ciitizen for $325M

Jury Awards ArcherDx, MGH $4.7M in Qiagen Patent Infringement Lawsuit

Top Five Articles on 360Dx Last Week: CDC Withdraws EUA Test; Qiagen Gets EUA for Antigen Test; More

Invitae Writes off $262.5M Liability Upon Failure to Meet Regulatory Milestone

Invitae More Than Doubles Q2 Revenues

360Dx Index Continues Growth in July, Increasing 5 Percent